Brief introduction of Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd.

Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. is a modern joint-stock high-tech enterprise established in February 2003 on the basis of the restructuring of the pharmaceutical factory of West China Medical University founded by 1958. The registered capital of the company is 80 million yuan, and its shareholders are composed of Sichuan Sichuan University Science and Technology Industry Group Co., Ltd., Sichuan Hanlinyuan Technology Co., Ltd., Chengdu Innovation and Venture Capital Co., Ltd., International Exchange and Cooperation Center of the Ministry of Health, and Sichuan Road and Bridge Construction Group Co., Ltd. After more than 50 years of pioneering struggle and expansion, supported by cutting-edge university technology and culture, it has achieved good social and economic benefits. At present, the company has developed into a first-class modern medium-sized pharmaceutical enterprise featuring the research and development, production and international trade of cardiovascular and cerebrovascular drugs and family planning products.

Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. covers an area of 1 10 mu, with a construction area of 43,700 square meters, which consists of two parts; Part of it is located in West China Campus of Sichuan University (the original campus of West China University of Medical Sciences), and has a particle workshop certified by the national GMP; The other part is located in Chengdu High-tech Industrial Development Zone, with modern workshops for Chinese medicine extraction, small-volume injections and solid preparations. All of them have passed the national drug GMP certification. The company is located in the factory area of Chengdu High-tech Industrial Development Zone, covering an area of 78 mu, and has a multi-dosage form and multi-variety modern production workshop that has passed GMP certification. The main products are Lemai granules, Shengmai injection, Shenmai injection, Xindakang tablets, levonorgestrel ethinyl estradiol tablets, Tongqiao Biyan capsules and more than 50 varieties. The sales business covers 365,438+0 provinces, municipalities and autonomous regions in China and has a stable overseas market. Export products are very popular in Japan. At present, it is gradually expanding to international markets such as Vietnam and Canada. The company's family planning products are products purchased by the national government. The company has been awarded "Top 30 Best Benefit Enterprises in Sichuan Pharmaceutical Manufacturing Industry", "Key Advantage Enterprises", "Small Giant Enterprises in Sichuan Province" and "A-level Tax Credit Rating", and Huaxi Shenmai Injection and Lemai Granule have been awarded "Sichuan Famous Brand Product Title" and other honors.